《华西药学杂志》2019~2023年刊载的基金论文分析  

Analysis of the fund-sponsored articles from West China Journal of Pharmaceutical Sciences in 2019-2023 years

作　　者：李容[1] 杨红芸[1] 朱欣然 LI Rong;YANG Hongyun;ZHU Xinran(West China School of Pharmacy,Sichuan University,Chengdu,Sichuan,610041 P.R.China;Sichuan Provincial Pharmaceutical Association,Chengdu,Sichuan,610041 P.R.China)

机构地区：[1]四川大学华西药学院,四川成都610041 [2]四川省药学会,四川成都610041

出　　处：《华西药学杂志》2024年第6期720-721,共2页West China Journal of Pharmaceutical Sciences

基　　金：四川大学科研基金(编号:17H1104)。

摘　　要：采用文献计量学方法,对《华西药学杂志》2019~2023年期间发表的基金论文进行统计与分析。该刊刊载的基金论文的比例呈逐年上升趋势,且基金级别高、基金来源分布较广,说明该刊的学术水平较高,社会影响力较广。The fund-sponsored articles published in"West China Journal of Pharmaceutical Sciences"(WCJPS)from 2019 to 2023 were to analyzed by the bibliometric methods.The results show that the proportion of fund-sponsored articles in WCJPS has been increasing yearly,with high-level funds and diverse funding sources.This indicates that WCJPS has a high academic level and a wide social impact.

关 键 词：基金论文 华西药学杂志 统计分析 作者分布 

分 类 号：G232[文化科学]